Vontobel Holding’s Shockwave Medical, Inc. Common Stock SWAV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-1,834
Closed -$597K 1168
2024
Q1
$597K Sell
1,834
-1,089
-37% -$267K ﹤0.01% 720
2023
Q4
$557K Sell
2,923
-565
-16% -$107K ﹤0.01% 770
2023
Q3
$694K Buy
3,488
+1,390
+66% +$329K 0.01% 672
2023
Q2
$599K Sell
2,098
-6,226
-75% -$1.73M 0.01% 745
2023
Q1
$1.8M Buy
8,324
+751
+10% +$146K 0.02% 435
2022
Q4
$1.57M Sell
7,573
-70
-0.9% -$17.7K 0.02% 469
2022
Q3
$2.13M Buy
7,643
+2,101
+38% +$534K 0.02% 391
2022
Q2
$1.06M Buy
5,542
+3,581
+183% +$632K 0.01% 533
2022
Q1
$407K Buy
+1,961
New +$323K ﹤0.01% 847
2021
Q2
Sell
-3,384
Closed -$441K 1192
2021
Q1
$441K Buy
+3,384
New +$406K ﹤0.01% 704

Other funds holding SWAV

Vontobel Holding's SWAV Position: Q2 2024 in Review

Vontobel Holding sold out of Shockwave Medical, Inc. Common Stock (SWAV) in Q2 2024, closing a stake of 1,834 shares — an estimated $597K sold.

Vontobel Holding first reported a position in SWAV in Q1 2021 and held it in 10 quarters. The position peaked at $2.13M in Q3 2022. 7 funds tracked by Wall St. Rank hold SWAV as of Q2 2024.

  • Vontobel Holding reported no remaining Shockwave Medical, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • Vontobel Holding sold 1,834 Shockwave Medical, Inc. Common Stock shares in Q2 2024, an estimated $597K.
  • Vontobel Holding first reported a position in Shockwave Medical, Inc. Common Stock in Q1 2021 and held it in 10 quarters.
  • Vontobel Holding's Shockwave Medical, Inc. Common Stock position peaked at $2.13M in Q3 2022.
  • 7 funds tracked by Wall St. Rank held Shockwave Medical, Inc. Common Stock as of Q2 2024.

Based on Vontobel Holding's 13F filing for Q2 2024, filed 13 Aug 2024.